[1] Shan Z, Yang G, Xiang W, et al. Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro [J]. J Cancer Res Clin Oncol, 2014, 140(3):371-374. [2] Lu L, Xue X, Lan J, et al. MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis [J]. Biomed Pharmacother, 2014, 68(1):13-19. [3] Xu R, Zeng G, Gao J, et al. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1 [J]. Oncol Rep, 2015, 34(4):2171-2178. [4] 韩影,苏彤,林璐,等.口腔癌对侧颈淋巴结转移的临床研究[J].口腔医学研究,2016,32(2):154-157. [5] Cheng KC, Cahill DS, Kasai H, et al. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions [J]. J Biol Chem, 1992, 267(1):166-172. [6] Leiros I, Nabong MP, Grosvik K, et al. Structural basis for enzymatic excision of N1-methyladenine and N3-methylcytosine from DNA [J]. EMBO J, 2014, 26(8):2206-2217. [7] Bowerman B. Cell biology. Oxidative stress and cancer: a beta-catenin convergence [J]. Science, 2005, 308(5725):1119-1120. [8] Gad H, Koolmeister T, Jemth AS, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool [J]. Nature, 2014, 508(7495):215-221. [9] Nakabeppu Y, Oka S, Sheng Z, et al. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase [J]. Mutat Res, 2010, 703(1):51-58. [10] Nakabeppu Y. Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells [J]. Int J Mol Sci, 2014, 15(7):12543-12557. [11] Brozmanová J, Dudás A, Henriques JA. Repair of oxidative DNA damage--an important factor reducing cancer risk. Minireview [J]. Neoplasma, 2001, 48(2):85-93. [12] Sakai Y, Furuichi M, Takahashi M, et al. A molecular basis for the selective recognition of 2-hydroxy--dATP and 8-oxo-dGTP by human MTH1 [J]. J Biol Chem, 2002, 277(10):8579-8587. [13] Nakabeppu Y. Molecular genetics and structural biology of human MutT homolog, MTH1 [J]. Mutat Res, 2001, 477(1-2):59-70. [14] Qing X, Shao Z, Lv X, et al. Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species [J]. Anticancer Drugs, 2018, 29(4):341-352. [15] Abbas HHK, Alhamoudi KMH, Evans MD, et al. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good [J]. BMC Cancer, 2018, 18(1):423. [16] Tamura T, Ichikawa T, Nakahata S, et al. Loss of NDRG2 expression confers oral squamous cell carcinoma with enhanced metastatic potential [J]. Cancer Res, 2017, 77(9):2363-2374. [17] 陈震,郭燕.E-cadherin和Vimentin在OSCC上皮-间质转化中的作用及表达[J].口腔医学研究,2016,32(8):857-860. [18] Joseph JP, Harishankar MK, Pillai AA, et al. Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC [J]. Oral Oncol, 2018, 80:23-32. [19] Hong KO, Kim JH, Hong JS, et al. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells [J]. J Exp Clin Cancer Res, 2009, 28(1):28. [20] Li J, Yang CC, Tian XY, et al. MutT-related proteins are novel progression and prognostic markers for colorectal cancer [J]. Oncotarget, 2017, 8(62):105714-105726. [21] Giribaldi MG, Munoz A, Halvorsen K, et al. MTH1 expression is required for effective transformation by oncogenic HRAS [J]. Oncotarget, 2015, 6(13):11519-11529. |